Bromoxidine en es it fr

Bromoxidine Brand names, Bromoxidine Analogs

Bromoxidine Brand Names Mixture

  • None

Bromoxidine Chemical_Formula

C11H10BrN5

Bromoxidine RX_link

http://www.rxlist.com/cgi/generic3/alphagan-p.htm

Bromoxidine fda sheet

Bromoxidine FDA

Bromoxidine msds (material safety sheet)

Bromoxidine MSDS

Bromoxidine Synthesis Reference

M. B. Thomas, M. T. Williams, Ger. Pat. 2,538,630 (1976 to Pfizer)

Bromoxidine Molecular Weight

292.135 g/mol

Bromoxidine Melting Point

207.5 oC

Bromoxidine H2O Solubility

Soluble (1.5 mg/mL)

Bromoxidine State

Solid

Bromoxidine LogP

0.782

Bromoxidine Dosage Forms

0.2% solution

Bromoxidine Indication

For the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Bromoxidine Pharmacology

Brimonidine significantly lowers intraocular pressure with minimal effects on cardiovascular and pulmonary parameters. It lowers intraocular pressure by reducing aqueous humor production and increasing uveoscleral outflow.

Bromoxidine Absorption

Minimal systemic absorption occurs after ocular insertion.

Bromoxidine side effects and Toxicity

Oral LD50 is 50 mg/kg in mice and 100 mg/kg in rats.

Bromoxidine Patient Information

PATIENT INFORMATION
Brimonidine tartrate is used for the treatment of open-angle glaucoma and ocular hypertension. Do not take this drug if you are currently taking MAO Inhibitors (e.g., Parnate). Inform your doctor if you are pregnant or nursing.
This product may stain soft contact lenses. Wait at least 15 minutes after instilling brimonidine to insert contact lenses.
May cause drowsiness or tiredness; use caution while driving or operating hazardous machinery. May cause dry mouth, blurring, stinging, or burning of the eyes; headaches, fatigue or drowsiness; allergic or itching of the eyes. Tell your doctor or pharmacist if these effects occur.

Bromoxidine Organisms Affected

Humans and other mammals